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Background: The relationships between sleep and headaches are complex and manifold. About the variety of
phenomena that can disrupt the sleep macrostructure and can impact its restorative function, the periodic limb
movements disorder (PLMd) can be considered as the most powerful.
No studies are known about the role of PLMd in the pathophysiology of migraine in children.
Aim of study is to assess the prevalence of PLMd and migraine and their relationship with disability and pain
intensity in a pediatric sample, referred for migraine without aura by pediatricians.
Methods: After a preliminary sleep habits screening with the Sleep Disturbances Scale for Children, 34 migraine
subjects affected by migraine without aura (20 M, 14 F) (mean age 9.08; SD ± 2.28) and 51 volunteers healthy
children (28 M, 23 F) (mean age 9.37; SD ± 1.81) accepted to underwent overnight PSG recordings in the Sleep
Laboratory of the Clinic of Child and Adolescent Neuropsychiatry, in order to define the macrostructural sleep
characteristics and the prevalence of PLMd. Subsequently, the migraineurs sample was studied in order to define
the relationship between disability, pain intensity, therapeutical responsiveness and the presence of PLMd.
Results: In the migraineurs children group, the individuals with PLM pathological index (PLMI ≥ 5) represent the
26.47% of sample and present higher frequency (p < 0.001), intensity (p < 0.001), duration (p = 0.006) and life
impairment as scored in the PedMIDAS (p < 0.001) of headache and lower efficacy of prophylactic (p = 0.001) and
acute (p = 0.006) pharmacological treatment than MoA children without PLM pathological index.
Conclusions: This preliminary study indicates the potential value of the determination of the PLMd signs, and the
importance of the PSG evaluation in children affected by migraine, particularly when the clinical and
pharmacological management tend to fail in the attacks control.
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The relationships between sleep and headaches are com-
plex and manifold [1,2], with suggestions for an unique
pathogenic process [3]. Among the causes of disturbed
sleep in subjects affected by primary headache, the sleep
apnea syndrome and the restless legs syndrome (RLS)
were considered yet in 1990 by Sahota and Dexter [4].
In particular, RLS is a sensorimotor disorder characterized
by an irresistible urge to move the limbs predominantly in* Correspondence: pasquale.parisi@uniroma1.it
2Child Neurology, Chair of Pediatrics, NESMOS Department, Faculty of
Medicine & Psychology, Sapienza University, Via di Grottarossa, 1035-1039,
Rome 00189, Italy
Full list of author information is available at the end of the article
© 2013 Esposito et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is pthe evening or at night, usually accompanied by a pe-
culiar discomfort in the lower extremities often alluded
to as a “creepy” or “crawly” feeling, with insomnia and
daytime fatigue as a consequence [5,6]. The nocturnal
polysomnography (PSG) may show the association of
periodic limb movement disorder (PLMd) during the
night.
According to the International Classification of Sleep
Disorders - 2nd Edition (ICSD-2) criteria, Periodic Limb
Movement Disorder (PLMd) is caused by periodic epi-
sodes of repetitive, highly stereotyped, limb movements
that occur during sleep, with a frequency >15/h (inan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ance or a complaint of daytime fatigue [7].
Specifically, a leg movement is classified as PLM if it is
part of a periodic sequence of leg movements which in-
volve the rhythmic extension of the big toe and dorsi-
flexion of the ankle, occasionally accompanied by knee
and hip flexion. By definition, periodic limb movements
are not the result of generalized neurological disorders,
which are typically apparent during wakefulness as well
as during sleep [8], and defined as four or more con-
secutive leg movements with a duration of 0.5-10 s, with
an EMG increase of >8 μV above the resting baseline,
and a minimum interval of 5 s and a maximum of 90 s
between two consecutive leg movements [9,10].
In general, about the variety of phenomena that can
disrupt the sleep macrostructure and can impact its re-
storative function [9,11], the PLMd could be considered
one as the most powerful.
Although the effects of PLMd have been well studied
in adults, there have been limited and scarce reports in
developmental age, associated with transient arousals
and sleep fragmentation, which could lead to changes in
daytime neurocognitive and behavioral patterns [12].
In children, the presence of PLMd may be frequently
associated with low serum iron and with a tendency
toward low serum ferritin levels [13].
Moreover, more conditions such as obstructive sleep
apnea syndrome (OSAS), autism, ADHD, Williams syn-
drome, Tourette syndrome, narcolepsy, and medications
like selective serotonin reuptake inhibitors, lithium and tri-
cyclic antidepressants can be considered as risk factors for
PLMd [14]. Since the description in adults in the 1980’s,
their prevalence in children and adolescents is still unclear.
Reported prevalence rates of the PLMd a frequency at least
of 5/hr vary between 1.2% to 10% of children not referred
specifically for PLMd or restless legs syndrome (RLS)
[15,16], while the prevalence in children with migraine is
largely unknown. Chervin and Hedger [17] reported that
restlessness of the legs, growing pains in bed, insomnia,
and morning headache can be considered as moderately
predictive value for the identification of paediatric PLMd.
To our knowledge, there are no data about the rela-
tionship between PLMd and migraine in developmental
age, and the putative common mechanisms underlying
the two conditions.
Therefore, the aim of the present study is to assess the
prevalence of PLMd and migraine and their relationship
with disability and pain intensity in a pediatric sample of
children affected by migraine without aura.
Methods
Study population
187 children affected by migraine without aura (MoA)
(74 F, 113 M) aged 5–17 years, (mean 9.92 ± 2.86) wereconsecutively referred to the Center for Childhood Head-
ache of Child and Adolescent Neuropsychiatry Clinic at
the Second University of Naples, from September 2011 to
December 2012. They were all referred from primary care
paediatricians.
The diagnosis of MoA was made according to the
International Classification of Headache Disorders. 2nd
Edition (ICHD-2) [18].
All mother’s of starting population subjects filled out a
questionnaire in order to assess the sleep habits (Sleep
Disturbances Scale for Children, SDSC) of their children
and compared with a control group composed by 766
typical developing children (342 F, 424 M; mean age
10.05 ± 2.13) comparable for age (p = 0.494) and sex
distribution (Chi-square =1.374; p = 0.241), recruited in
the Campania Region schools.
Therefore, from original population of 187 migraine
children the subjects with SBD referred signs, EEGs
abnormalities or epileptic discharges, neuro-anatomical
alterations (assessed by RMN and/or TC evaluation) or
psychiatric illness (depression, behavioural problems and
ADHD) or mental retardation (IQ ≤70) or subjects
under treatment with anticonvulsant or psychoactive
drugs were excluded.
Finally, only 34 migraine subjects affected by MoA (20
M, 14 F) (mean age 9.08; SD ± 2.28) and 51 volunteers
typical developing children (28 M, 23 F) (mean age 9.37;
SD ± 1.81) accepted to underwent overnight PSG
recordings.
All the subjects were recruited from the same urban
area, were all Caucasian origin, and had middle socio-
economic status.
All evaluations were performed after informed paren-
tal consent was obtained for all the children enrolled,
according to the World Medical Association [19].
The study was approved by the Departmental Ethics
Committee at the Second University of Naples.
Biochemical evaluation
In order to exclude the presence of alteration in iron
metabolism (low serum iron and low serum ferritin
levels), the blood samples for hemoglobin, and iron sta-
tus evaluations were drawn in the morning (at 08:00 h)
after overnight fasting. Hemoglobin was measured in
whole blood using an automated Coulter counter, and
cut-off points used to define anemia were based on the
5th percentiles for the reference groups [20].
In particular, the iron status has been assessed by
serum iron, transferrin, and ferritin concentrations.
Transferrin saturation has been calculated.
Particularly for serum iron, an iron ferrozine complex
method was used with sensitivity of 5 μg/dl; serum trans-
ferring was measured using a turbidimetric method with
sensitivity of 70 mg/dl. Serum ferritin was measured by
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lated by finding the molar ratio of serum iron and twice
the serum transferring (because each transferrin molecule
can bind two atoms of iron) using the formula:
transferrin saturation ¼ serum iron micrograms per deciliterð Þ=½
transferrin milligrams per deciliterð Þ
71:2:
Anthropometric evaluation
In order to exclude subjects with overweight or obesity,
weight and height were measured and BMI was calcu-
lated. Standard deviations scores for BMI were calcu-
lated by using the LMS method [21].
Sleep habits assessment
To evaluate sleep habits and disturbances, all mother’s of
starting population subjects filled out the Sleep Distur-
bances Scale for Children (SDSC) questionnaire [22]. This
is a standardized questionnaire for the assessment of
pediatric sleep problems consisting of 26 items grouped
into 6 subscales: DIMS (Disorders in Initiating and
Maintaining Sleep), SBD (Sleep Breathing Disorders), DA
(Disorders of Arousal), SWTD (Sleep-Wake Transition
Disorders), DOES (Disorders Of Excessive Somnolence),
SHY (Nocturnal Hyperhydrosis). The SDSC questionnaire
is widely used in school-aged children both in the original
[22,23] or as modified version [24].
The results were compared with those obtained by
SDSC questionnaires of a control group composed
by 766 children (342 F, 424 M; mean age 10.05 ±
2.13) matched for age (p = 0.494) and sex distribution
(Chi-square =1.374; p = 0.241), recruited in the Campania
region schools.
The subjects of both groups were recruited from the
same urban area, were all Caucasian origin, and had
middle socioeconomic status.
Polysomnographic sleep recordings
34 migraine subjects affected by MoA (20 M, 14 F)
(mean age 9.08; SD ± 2.28) and 51 volunteers healthy
children (28 M, 23 F) (mean age 9.37; SD ± 1.81) ac-
cepted to underwent overnight PSG recordings in the
Sleep Laboratory of the Clinic of Child and Adolescent
Neuropsychiatry, after one adaptation night, in order to
avoid the “first-night effect”. The groups that underwent
PSG were matched for age (p = 0.516), and gender distri-
bution (Chi-square = 0.018; p = 0.893).
As previously reported in other polysomnographic
studies [25-28], electroencephalographic (EEG) record-
ings and electrode placement were performed according
to the 10–20 system [29] and the polysomnographicmontage included at least 19 EEG channels (Fp2, Fp1,
F3, F4, F7, F8, C3, C4, T3, T4, P3, P4, T5, T6, O1, O2,
Fz, Cz, Pz) referenced to the contralateral mastoid, left
and right electro-oculogram, chin electromyogram, left
and right tibialis electromyogram, electrocardiogram
(one derivation), nasal cannula, thorax and abdominal
effort, peripheral oxygen saturation, pulse, and position
sensors.
The recordings were carried out using a Brain Quick
Micromed System 98 recording machine, and signals
were sampled at 256 Hz and stored on a hard disk for
further analysis. EEG signals were digitally band-pass
filtered at 0.1–120 Hz, with 12-bit A/D precision. Sleep
signals were sampled at 200 Hz or 256 Hz and stored on
a hard disk in European data format for further analysis.
EEG signals were first acquired with a wide band analog
filter (0.001–70 Hz) and then digitally band-pass filtered
at 0.1–50 Hz. All recordings started at the subjects’
usual bedtime and continued until spontaneous morning
awakening.
Sleep stage scoring
Sleep was subdivided into 30-second epochs, and sleep
stages were scored using standard criteria [30].
The following conventional sleep parameters were
evaluated:
 Time in bed
 Sleep period time: time from sleep onset to end of
sleep
 Total sleep time: time from sleep onset to the end of
the final sleep epoch minus time awake
 Sleep latency: time from lights out to sleep onset,
defined as the first of two consecutive epochs of
stage 1 sleep or one epoch of any other stage, in
minutes
 REM latency: time from sleep onset to the first REM
sleep epoch
 Number of stage shifts/hour
 Number of awakenings/hour
 Sleep efficiency: percentage ratio between total sleep
time and time in bed (total sleep time/time in bed * 100)
 Percentage of sleep period time spent in wakefulness
after sleep onset, i.e., time spent awake between
sleep onset and end of sleep
 Percentage of sleep period time spent in sleep stages
1 (S1%) and 2 (S2%), slow-wave sleep (SWS%), and
REM sleep (REM%)
All variables were analyzed by Hypnolab 1.2 sleep soft-
ware analysis (SWS Soft, Troina, Italy). All recordings
were visually scored by one of the investigators (MC),
and the sleep parameters derived were tabulated for stat-
istical analysis.
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breathing disorders, nocturnal respiratory parameters
(i.e., central, obstructive, and mixed apnea events) were
counted using standard criteria [31].
The apnea-hypopnea index was defined as the number
of apneas and hypopneas per hour of total sleep time; an
obstructive apnea index ≥1 was selected as the cutoff for
normality [32,33].
Standard criteria were used to identify episodes of
periodic limb movements. The frequency of leg move-
ments was represented as the periodic leg movement
index (number/hour of total sleep time). Episodes of
periodic limb movements were defined as leg move-
ments with an amplitude increase of 8 μV above the
baseline value, a duration of 0.5–10 seconds, a period
length between two consecutive movements of 5–90
seconds, and a minimum of four consecutive move-
ments [9]. A periodic leg movement index ≥ 5 was con-
sidered abnormal.
Migraine evaluation
In the MoA group, in order to compare the headache
characteristics between children with PLMd and children
without PLMd (no-PLMd), we take in account the MoA
frequency and the duration of headache attacks per
month, the pain intensity (VAS index), the PedMIDAS
score, and the subjective response to the pharmaco-
logical treatment such as acute treatment (i.e.: Para-
cetamol efficacy) and prophylactic treatment (Preventive
therapy efficacy; i.e.: Flunarizine) obtained by the clinical
interview.
The visual analogue scale (VAS) was used to assess the
level of pain, by placing a mark on an horizontal line 10-cm
long at an appropriate distance between the two endpoints
(no pain signed as happy smiley and most intense pain
imaginable signed as hopeless smiley).
The PedMIDAS is a sensitive, six-question interview
that can be easily administered by both parent and child
to assess the impact of recurrent headaches on a child’s
life. This tool has been shown to be reliable and valid for
assessing disability in children and adolescents and was
found to be easy to complete and use within an active
clinical setting. It can provide the impact of migraines
on a child’s day-to-day activity and overall quality of life.
The instrument also provides a useful tool to assess
treatment outcomes and compare responses to individ-
ual therapies [34].
Statistical analysis
In order to compare the biochemical, anthropometric
characteristics of both populations a t-Test and the
Chi-square test, when appropriate, were performed.
To evaluate the differences in the sleep items patho-
logical score of the SDSC in the original populations, acut-off of at least 3 episodes per week was considered,
according to the validation criteria [22]. Therefore, the
Chi-Square test was used to analyse the results.
In order to select from the original sample (MoA
and normal), a representative group for PSG record-
ings the sample size was calculated with the on line
software http://www.dssresearch.com/toolkit/sscalc/size_a2.
asp with an Alpha Error Level at 5% and Beta Error
Level at 50%.
In the group who underwent PSG study (34 MoA vs.
51 normal children), the comparisons between sleep
architecture parameters were conducted using the non-
parametric Mann–Whitney U test for independent data
sets [35].
In order to evaluate the PLMd influence on headache
characteristics, the MoA sample was divided in two
groups accordingly the periodic limb movement index
(PLMI) ≥5/h [9]. Then, the t-Test and, when appropri-
ate, the Chi-square test were performed to compare
MoA characteristics (i.e. frequency, intensity, duration of
attacks, life impairment and treatment efficacy) of two
subgroups (MoA children with PLMI > 5/h and children
with MoA with PLMI < 5/h).
In order to analyze the relationship among PLMI with
frequency, duration, intensity and disability of MoA chil-
dren, the Pearson’s correlation test was computed.
For all statistical analysis, p values <0.05 were consid-
ered significant.
Results
Table 1 shows the comparison on the 26 SDSC items
based on the “pathological score cut-off” (≥3/week) of
both samples. MoA children show an higher quote of
difficulty to falling asleep (Sleep latency ≥30 min p <
0.001, Difficulty getting to sleep at night p < 0.001, Anxiety
when falling asleep p <0.001, Hypnic jerks p value = 0.009)
and NREM parasomnias signs (Sleepwalking; p < 0.001
and Sleep talking; p =0.002) and sleep related movement
disorders (Teeth grinding; p <0.001) in SDSC sub-items
than control group.
According to the sample size calculation, the size of both
groups who underwent PSG (34 migraine and 51 normal
children) was representative of starting population.
Table 2 shows the comparison between biochemical
and anthropometric characteristics of both PSG study
population.
Table 3 shows the statistical comparison between the
sleep architecture parameters of MoA children and con-
trol group. MoA children present a reduction of TIB (p <
0.001), SPT (p < 0.001), TST (p < 0.001) with an higher
quote of awakenings per hour (p = 0.008) and a higher
PLM index (p < 0.001) than controls.
There were not differences in sleep stage percentages
and in respiratory indexes, such as apnea/hypopnea
Table 1 Sleep habits in migraine without aura and control children
SDSC items MoA (n = 187) (%) Control (n = 766) (%) Chi-square p<
1. Sleep less than 8 h 13.90 16.32 0.49 NS
2. Sleep latency >30 min 18.72 6.53 26.01 0.0000
3. Reluctant to go to bed 43.32 36.95 2.32 NS
4. Difficulty getting to sleep at night 27.27 16.45 10.94 0.0000
5. Anxiety when falling asleep 32.09 7.70 79.56 0.0000
6. Hypnic jerks 20.86 13.05 6.73 0.0090
7. Rhythmic movements while falling asleep 12.30 8.62 1.99 NS
8. Vivid dream-like scenes while falling asleep 13.90 5.09 17.01 0.0000
9. Falling asleep sweating 24.60 10.18 26.34 0.0000
10. More than two awkenings per night 17.11 12.40 2.49 NS
11. Difficulty to fall asleep after awakenings 17.11 12.66 2.18 NS
12. Nocturnal hyperkinesias 47.06 37.99 4.79 0.029
13. Sleep breathing difficulties 12.59 12.40 0.007 NS
14. Sleep apnea 4.27 4.18 0.02 NS
15. Snoring 17.11 17.23 0.005 NS
16. Night sweating 13.36 13.19 0.003 NS
17. Sleepwalking 14.97 6.66 12.60 0.0000
18. Sleep talking 28.88 18.15 10.06 0.0020
19. Teeth grinding 16.58 6.79 16.91 0.0000
20. Sleep terrors 9.09 5.09 3.65 NS
21. Nightmares 11.76 12.01 0.001 NS
22. Difficulty in waking up in the morning 33.69 32.38 0.07 NS
23. Feeling tired awakening in the morning 35.83 27.94 4.13 0.0420
24. Sleep paralysis 8.02 7.57 0.00 NS
25. Daytime somnolence 13.37 9.40 2.18 NS
26. Sleep attacks 4.81 3.13 0.82 NS
The Table 1 shows the percentage of pathological score for all the 26 items of Sleep Disturbance Scale for Children, according with the validation
criteria (>3/week).
Table 2 Demographic, anthropometric and biochemical
evaluation in MoA and normal comparisons, who
underwent the polysomnographic study
MoA (n = 34) Control (n = 51) p
Age 10.67 ± 2.6 10.92 ± 2.37 0.653
Sex ratio (M/F) 20/14 28/23 0.893
z-BMI (z score Body
Mass Index)
0.31 ± 0.43 0.21 ± 0.37 0.256
Hemoglobin (g/dL) 13.04 ± 0.97 13.1 ± 1.05 0.791
Serum iron, (μg/dL) 80.30 ± 17.21 79.95 ± 18.04 0.929
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tween the two groups.
In the MoA group, the children with PLMI ≥ 5 repre-
sent the 26.47% of sample and present higher frequency
(p < 0.001), intensity (p < 0.001), duration (p = 0.006) and
life impairment of headache as scored in the PedMIDAS
(p < 0.001), than those with PLMI < 5/h. They had also
a lower efficacy of prophylactic (p = 0.001) and acute
(p = 0.006) pharmacological treatment (Table 4).
Moreover, the Pearson’s analysis shows a positive correl-
ation between PLMI and frequency (r = .5925; p < 0.001),
intensity (r = .4922; p = 0.003), duration (r = .3968; p = 0.02)
and disability due to migraine (r = .6931; p < 0.001).Serum ferritin, (μg/L) 34.5 ± 16.2 31.97 ± 15.1 0.464
Transferrin saturation (%) 23.51 ± 5.14 22.76 ± 6.32 0.571
Table 2 shows the comparison between demographic and hematologic
characteristics of both PSG study population.
In order to verify the matching about sex ratio (M/F) the Chi-square test was
performed; all other characteristics was evaluated applying t-Test.Discussion
The main findings of our study can be summarised in
the assessing of PLMd prevalence in children affected by
MoA, and in the identification as potential causative role
Table 3 Sleep macrostructural, respiratory parameters and PLM nocturnal evaluation
Migraine (N = 34) Control (N = 51) Mann–Whitney
Mean Std.Dev. Mean Std.Dev. U p
TIB-min 467.3235 46.46502 595.1961 86.57985 126.00 0.000
SPT-min 445.1765 47.29980 562.4412 80.85330 147.00 0.000
TST-min 416.3529 59.19837 534.3824 75.29167 135.00 0.000
SOL-min 14.6324 11.61524 22.7843 21.93109 643.5 NS
FRL-min 142.2206 53.99385 125.2941 50.83268 706.00 NS
SS-h 9.2824 2.52976 8.7686 3.44078 74.5 NS
AWN-h 3.8971 2.59364 2.1784 1.79881 527.5 0.008
SE % 88.8441 7.41261 90.0216 5.47640 845.5 NS
WASO-spt (%) 6.7147 7.16139 4.8471 4.08545 779.5 NS
S1-spt (%) 1.7882 2.07259 2.8000 3.47338 621.00 NS
S2-spt (%) 38.9588 9.10265 43.6451 24.84550 797.00 NS
SWS-spt (%) 34.7735 10.46907 30.9490 9.97830 698.5 NS
REM-spt (%) 17.7382 6.68839 21.1961 5.43463 620.5 NS
AHI 0.9512 0.35743 0.8463 0.29067 675.00 NS
ODI 0.3821 0.26759 0.3837 0.32744 813.5 NS
PLMI 18.3194 24.850 2.5333 1.11187 65.5 0.000
Table 3 shows the mean differences in sleep macrostructure, respiratory (AHI, ODI) and PLM index (PLMI) between the migraine and control group, calculated
with t-Test analysis.
TIB time in bed, SPT sleep period time, TST total sleep time, SOL sleep onset latency, FRL first REM sleep latency, SS stage shifts, AWN awakenings, SE sleep
efficiency, WASO wake time after sleep onset, S1 sleep stage 1, S2 sleep stage 2, SWS slow-wave sleep, REM rapid eye movement sleep percentage.
AHI apnea/hypopnea index (normal value≤1/h), ODI oxygen desaturation index (normal value≤ 1/h), PLMI periodic limb movements index (normal value≤ 5%). NS
not significant.
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affected by migraine without aura.
In general, the inter-relationship between sleep and
headache seems to interest also the sleep length: an
excess or lack of sleep or a bad quality or inadequate
duration of sleep could cause headache [2,4].
In fact, the short sleepers tend to exhibit significantly
more frequent headaches than long sleepers and were
also more likely to experience morning headaches at
awakening [36].
Moreover, previous studies described the differences in
sleep habits such as a higher quote of DIMS, SBD, DA,
SWTD and DES categories [37], and in the sleep macro-
structure such as a reduction in total sleep time (TST),Table 4 Comparison about pain characteristics, disability
and treatment efficacy between MoA children with
p values <0.05 was considered significant
PLMI > 5/h (9) PLMI < 5/h (25) p
Frequency attacks/month 15.667 ± 2.236 6.840 ± 2.838 0.000
VAS 8.444 ± 1.014 5.200 ± 1.848 0.000
Duration 8.778 ± 2.108 5.320 ± 3.262 0.024
PedMIDAS score 63.556 ± 5.27 24.88 ± 10.41 0.000
Paracetamol efficacy 1/8 18/7 0.012
Preventive therapy efficacy 2/7 22/3 0.002
p values <0.05 were considered significant.rapid eye movement (REM) and slow-wave sleep (SWS),
and an increased sleep latency (SOL) [38] between head-
ache children respect of normal children, as confirmed
by our findings.
In particular, our findings tend to confirm the reported
differences respect of typical developing comparisons
such as a higher sleep latency, higher rate in difficulty
getting to sleep at night, anxiety when falling asleep,
hypnic jerks, NREM parasomnias signs and sleep related
movement disorders in SDSC subitems than control
group. Moreover, accordingly with Vendrame study re-
sults [38], our MoA children present a reduction in TIB
(p < 0.001), SPT (p < 0.001), and TST (p < 0.001) with a
higher quote of awakenings per hour (p = 0.008) and
PLM index (p < 0.001) than controls.
Alternatively, the PLMd have been reported with a vari-
able prevalence in developmental age, after the first de-
scription by Pichietti and Walters [39]. Genetic factors,
altered iron metabolism and dopaminergic dysfunction
have been thought to be involved in the pathophysiology
of PLMd.
Accordingly, in our sample all these disturbances and
alterations in iron metabolism were excluded.
Moreover, the present study, first tried to assess the
prevalence of PLMd according to the PSG diagnosis in
children with migraine that represents the 26.47% of our
migraine sample.
Esposito et al. The Journal of Headache and Pain 2013, 14:57 Page 7 of 8
http://www.thejournalofheadacheandpain.com/content/14/1/57Anyway, the lack of normative controls for prevalence
of “any PLMS” in the general population is also limiting,
as we cannot confidently infer how the prevalence of
“any PLMS” in children with migraine compares to the
prevalence in the general pediatric population.
On the other hand, migraine may be considered a pain-
ful disabling condition, particularly in childhood, and is
often accompanied by severe impairments, including low
quality emotional functioning, absenteeism from school,
and poor academic performance, as well as poor cognitive
functioning [40,41], motor coordination, [42] sleep habits
[37,38,43-49] and high maternal stress [50,51].
Otherwise, there is no consensus about the MoA ori-
gin, pathophysiology and long-term course, particularly
in the pediatric population [52], even if also several brain
neurotransmitter systems have been suggested to be in-
volved in migraine, such as glutamate, noradrenaline
and for neuromodulators and dopamine [53].
In this light, our data seem to suggest that PLMd
could influence the migraine clinical presentation, in-
creasing its severity, frequency and all disabling aspects,
such as the treatment efficacy also.
On the other hand, a recent report pinpointed a correl-
ation between the pain threshold in adults affected by mi-
graine and the sleep pressure, suggesting that migraineurs
on the average tend to suffer from a relative sleep
deprivation and need more sleep than healthy controls [54].
Conclusions
We should take into account the main limitation of this
study represented by the fact that our subjects came
from a small group from a specific region of Southern
Italy.
Notwithstanding these limitations, this could be con-
sidered the first report about the potential value of the
determination of the PLMd signs, and the importance of
the PSG evaluation in children affected by migraine, par-
ticularly when the clinical and pharmacological manage-
ment tend to fail in the attacks control.
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